tiprankstipranks
Trending News
More News >
Tarsus Pharmaceuticals (TARS)
NASDAQ:TARS
US Market

Tarsus Pharmaceuticals (TARS) Income Statement

Compare
257 Followers

Tarsus Pharmaceuticals Income Statement

Last quarter (Q3 2025), Tarsus Pharmaceuticals's total revenue was $118.70M, an increase of 146.68% from the same quarter last year. In Q3, Tarsus Pharmaceuticals's net income was $-12.59M. See Tarsus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 182.95M$ 17.45M$ 25.82M$ 57.03M$ 0.00
Gross Profit
$ 170.13M$ 15.85M$ 24.86M$ 54.95M$ -246.00K
Operating Expenses
$ 290.70M$ 159.01M$ 87.57M$ 67.11M$ 26.74M
Depreciation and Amortization
$ 1.23M$ 877.00K$ 326.00K$ 312.00K$ 246.00K
EBITDA
$ -106.48M$ -131.67M$ -59.70M$ -13.46M$ -26.56M
Operating Income
$ -120.57M$ -143.16M$ -62.71M$ -12.16M$ -26.98M
Other Income/Expenses
$ 5.01M$ 7.26M$ 617.00K$ -1.61M$ 173.00K
Pretax Income
$ -115.55M$ -135.89M$ -62.09M$ -13.77M$ -26.81M
Net Income
$ -115.55M$ -135.89M$ -62.09M$ -13.83M$ -26.81M
Per Share Metrics
Basic EPS
$ -3.07$ -4.62$ -2.52$ -0.67$ -1.32
Diluted EPS
$ -3.07$ -4.62$ -2.52$ -0.67$ -1.32
Weighted Average Shares Outstanding
37.60M 29.38M 24.62M 20.55M 20.32M
Weighted Average Shares Outstanding (Diluted)
37.60M 29.38M 24.62M 20.55M 20.32M
Currency in USD

Tarsus Pharmaceuticals Earnings and Revenue History